EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Trh potently reverses epinephrine stimulated hyperglycemia in mice


Brain Research 435(1-2): 112-122
Trh potently reverses epinephrine stimulated hyperglycemia in mice
Intracerebroventricular microinjection of thyrotropin-releasing hormone (TRH) potently blocked the development of, as well as promptly reversed, epinephrine-stimulated hyperglycemia in mice. The central antihyperglycemic effect was dose-related (0.1-10 .mu.g), could be reproduced by an intravenous injection of a large dose of the peptide (100 .mu.g), was independent of experimental factors such as stress and age, was effective against other hyperglycemic stimuli, and appeared to be unique to TRH, as it could not be mimicked by many other centrally active peptides known to influence glucoregulation in normoglycemic animals. Moreover, the antihyperglycemic effect of TRH appeared to depend on the structural integrity of the peptide molecule but seemed to be unrelated to the peptide's hypophysiotropic actions or to interaction of the peptide with previously characterized TRH receptors, as it could be mimicked by various analogs devoid of thyrotropin- and prolactin-releasing influences or by peptides resembling TRH in amino acid composition but lacking substantial binding affinity to TRH receptors. Furthermore, the effect of TRH to reverse epinephrine-stimulated hyperglycemia appeared to be mediated by combined action of peripheral sympathetic and parasympathetic mechanisms to stimulate insulin release from the pancreas, since only complete blockade of the central autonomic outflow, but not selective perturbation of the sympathetic or parasympathetic outflow, or depletion of pancreatic insulin could substantially attenuate the antihyperglycemic action. Taken together, these results suggest a new physiologic role of TRH as a central glucoregulatory neuropeptide involved in autonomic modulation of insulin secretion and prevention of hyperglycemia.


Accession: 006839776



Related references

Thyrotropin-releasing hormone potently reverses epinephrine-stimulated hyperglycemia in mice. Brain Research 435(1-2): 112-122, 1987

Trh potently antagonizes catecholamine induced hyperglycemia in mice. Society for Neuroscience Abstracts 12(1): 219, 1986

Cholestyramine reverses hyperglycemia and enhances glucose-stimulated glucagon-like peptide 1 release in Zucker diabetic fatty rats. Journal of Pharmacology and Experimental Therapeutics 334(1): 164-170, 2010

Acanthopanax senticosus reverses fatty liver disease and hyperglycemia in ob/ob mice. Archives of Pharmacal Research 29(9): 768-776, 2006

Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes 51(4): 1028-1034, 2002

Combination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 Diabetes. Diabetes 64(11): 3873-3884, 2016

Ciglitazone prevents and reverses dexamethasone-induced hyperglycemia in female viable yellow mice. International Journal of Obesity and Related Metabolic Disorders 16(11): 923-933, 1992

Heterozygous knock-out of IKKbeta reverses insulin resistance, hyperglycemia and dyslipidemia in obese mice. Diabetes 50(Supplement 2): A57-A58, June, 2001

Antagonistic effects of serotonin on epinephrine induced hyperglycemia in mice. Japanese Journal of Pharmacology 49(SUPPL): 184P, 1989

The absence of epinephrine-induced hyperglycemia inpertussis-sensitized mice. Fed Proc 21(2): 271, 1962